TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for Transthyretin Amyloidosis With Cardiomyopathy
Drug: Nucresiran
39 locations incl. La Jolla
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18 - 85
Code: NCT07052903·Phase 3·Recruiting